Cosmic ray impact on extrasolar earth-like planets in close-in habitable zones

Because of their different origins, cosmic rays can be subdivided into galactic cosmic rays and solar/stellar cosmic rays. The flux of cosmic rays to planetary surfaces is mainly determined by two planetary parameters: the atmospheric density and the strength of the internal magnetic moment. If a planet exhibits an extended magnetosphere, its surface will be protected from high-energy cosmic ray particles. We show that close-in extrasolar planets in the habitable zone of M stars are synchronously rotating with their host star because of the tidal interaction. For gravitationally locked planets the rotation period is equal to the orbital period, which is much longer than the rotation period expected for planets not subject to tidal locking. This results in a relatively small magnetic moment. We found that an Earth-like extrasolar planet, tidally locked in an orbit of 0.2 AU around an M star of 0.5 solar masses, has a rotation rate of 2% of that of the Earth. This results in a magnetic moment of less than 15% of the Earth's current magnetic moment. Therefore, close-in extrasolar planets seem not to be protected by extended Earth-like magnetospheres, and cosmic rays can reach almost the whole surface area of the upper atmosphere. Primary cosmic ray particles that interact with the atmosphere generate secondary energetic particles, a so-called cosmic ray shower. Some of the secondary particles can reach the surface of terrestrial planets when the surface pressure of the atmosphere is on the order of 1 bar or less. We propose that, depending on atmospheric pressure, biological systems on the surface of Earth-like extrasolar planets at close-in orbital distances can be strongly influenced by secondary cosmic rays.

Association scan of the novel psoriasis susceptibility region on chromosome 19: evidence for both susceptible and protective loci

To follow up the novel psoriasis susceptibility region on chromosome 19 (PSORS6), we performed an association scan for psoriasis vulgaris using 45 evenly spaced DNA microsatellite markers. For this study, a new independent sample of 210 nuclear psoriasis families (trio design) from Northern Germany was recruited. We used the family based association test (FBAT) for an association scan over the chromosome 19 region encompassing 50.8 cM. We obtained a positive association for the markers D19S922 (allele 5, P = 0.008) and D19S916 (allele 13, P = 0.016), which correspond to the peak of the region identified in a previously performed scan. We identified two novel regions by a single marker, each showing negative association at D19S917 on 19p13.1 (allele 8, P = 0.0034) and at D19S425 (allele 9, P = 0.0005), compatible with the hypothesis of protective loci. These two novel regions were explored in more detail using novel microsatellite markers at an average distance of 100 kb. A separate analysis distinguishing between familial (n = 137) and sporadic (n = 73) psoriasis families showed that the familial trios contribute strongly in the region around D19S425 (P = 0.004), while the comparably small subset of 73 sporadic trios has a stronger effect at the locus around D19S917 (P = 0.026). These studies confirm the existence of a psoriasis susceptibility locus on chromosome 19 and give first evidence for the existence of both susceptible and protective loci in this region. Analysis of a dense marker set from these refined regions will eventually allow identification of the underlying susceptibility alleles.

Gene expression and transcript size of the prepro-peptide VIP/PHM-27 in normal human tissue

The transcript size of VIP/PHM-27 mRNA (vasoactive intestinal peptide/peptide histidine methionine) and the relative distribution of VIP/PHM-27 gene expression in 10 normal human tissues was examined. After mRNA extraction from tissue, VIP/PHM-27 transcript size and relative abundance of mRNA was determined by Northern blot analysis and densitometry of the autoradiograms. VIP/PHM-27 mRNA was detectable in brain, pancreas, colon, ileum and striated muscle while no hybridization signal was observed in liver, kidney, lung, heart, prostate and placental tissue. VIP/PHM-27 transcript in human brain and gut was a single band of 1.7 kb; by contrast, a 7.0-kb transcript was detected in striated skeletal muscle. The highest relative levels of mRNA were observed in brain and pancreas.

[Nerve compression syndrome caused by synovial cyst of the hip joint]

Synovitis of the iliopectineal bursa have been described in pigmented villanodular synovitis, synovial chondromatosis, rheumatoid arthritis, osteoarthritis and necrosis of the femoral head. We report a case of enlargement of such a cyst in necrosis of femoral head and consecutive osteoarthritis, leading to entrapment of the femoral nerve. Simple drainage of the cyst did resolve pain for a short period and only elimination of the primum pathologicum agens did definitively release pain, irradiating to the ipsilateral leg.

Inhibitory action of a met-enkephalin on ACTH release in man

In order to study the mechanism of action of a Met-enkephalin (FK 33824) on the pituitary-adrenal axis eight normal male volunteers were subjected to an ACTH stimulation test. Lysine-vasopressing (LVP), 5 IU, was injected intramuscularly after pretreatment with 0.5 mg FK 33824 i.m. or a placebo. In six of the subjects the opiate was again administered preceding a single injection of 0.25 mg ACTH beta 1-24 i.m. Blood was collected at regular intervals and ACTH and cortisol concentrations analyzed in all samples. LVP induced significant plasma ACTH (P < 0.05) and cortisol (P < 0.001) increases. Pretreatment with FK 33824 completely antagonized the effect of LVP. Furthermore, the cortisol elevation after exogenous ACTH was not modified by previous administration of FK 33824. It is concluded that the Met-enkephalin derivative FK 33824 directly suppresses ACTH release from the pituitary without influencing adrenal synthesis of cortisol.